Seed · Biotech · Cambridge, United Kingdom · Founded 2022 · 1–10 employees
ZOMP is a deep-tech spinout from the University of Cambridge developing the ZOMP Parallax, a system designed to be the world's first 3D imaging flow cytometer. The company's proprietary LightGate technology combines high-throughput cell measurement with high-resolution, label-free, and multi-color 3D whole-cell imaging at population scale. This innovation enables researchers to capture subcellular spatial and morphological details of millions of cells, offering critical utility in immunotherapy, drug discovery, and cancer diagnosis. The startup validated its commercial potential by securing a £2 million seed funding round to advance its proprietary technology.
No open roles listed right now.